Unum Therapeutics Inc (NASDAQ:UMRX)

0.9493
Delayed Data
As of Jan 17
 -0.0157 / -1.63%
Today’s Change
0.48
Today|||52-Week Range
4.87
+31.81%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Biotechnology
MARKET CAP
$29.7M

Company Description

Unum Therapeutics, Inc. is a clinical-stage biopharmaceutical company focused on the development and commercialization of novel immunotherapy products designed to harness the power of a patient's immune system to cure cancer. The firm's technologies include Antibody-Coupled T-cell Receptor, which is a chimeric protein that binds to tumor targeting antibodies. The company was founded by Charles Wilson and Dario Campana in March 2014 and is headquartered in Cambridge, MA.

Contact Information

Unum Therapeutics, Inc.
200 Cambridge Park Drive
Cambridge Massachusetts 02140
P:(617) 945-5576
Investor Relations:

Employees

Shareholders

Individual stakeholders59.01%
Mutual fund holders5.36%
Other institutional15.31%

Top Executives

There are no executives to display.